Kaplan-Meier Estimates of Progression-Free Survival (PFS) in the Study Population
tumor, tumors
DISEASE, TUMORS, CROSS, TUMOR
Cross marks show data censored at the time of last disease assessment. ctDNA indicates circulating tumor DNA; ITT, intention to treat; and WT, wild type.In patients with pretreatment plasma Before rechallenge treatment, NGS liquid biopsy findings were available for 16 of 23 patients (69.6%) with For arm B, in 15 of 23 patients whose tumors were WT for 